Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
New medicines: human
Get the latest updates from New medicines: human directly as they happen.
Follow now 463 followers
Latest posts
Last updated 11 days ago
Human medicines European public assessment report (EPAR): Vivlipeg, pegfilgrastim, Status: Opinion
11 days ago
Human medicines European public assessment report (EPAR): Vivlipeg, pegfilgrastim, Status: Opinion
Human medicines European public assessment report (EPAR): Mynzepli, aflibercept, Status: Opinion
11 days ago
Human medicines European public assessment report (EPAR): Mynzepli, aflibercept, Status: Opinion
Human medicines European public assessment report (EPAR): Austedo, deutetrabenazine, Status: Opinion
11 days ago
Human medicines European public assessment report (EPAR): Austedo, deutetrabenazine, Status: Opinion
Human medicines European public assessment report (EPAR): Eiyzey, aflibercept, Status: Opinion
11 days ago
Human medicines European public assessment report (EPAR): Eiyzey, aflibercept, Status: Opinion
Human medicines European public assessment report (EPAR): Vgenfli, aflibercept, Status: Opinion
11 days ago
Human medicines European public assessment report (EPAR): Vgenfli, aflibercept, Status: Opinion
Human medicines European public assessment report (EPAR): Nintedanib Viatris, nintedanib, Status: Opinion
11 days ago
Human medicines European public assessment report (EPAR): Nintedanib Viatris, nintedanib, Status: Opinion
Human medicines European public assessment report (EPAR): Imreplys, sargramostim, Status: Opinion
11 days ago
Human medicines European public assessment report (EPAR): Imreplys, sargramostim, Status: Opinion
Human medicines European public assessment report (EPAR): Rezdiffra, resmetirom, Status: Opinion
11 days ago
Human medicines European public assessment report (EPAR): Rezdiffra, resmetirom, Status: Opinion
Human medicines European public assessment report (EPAR): Zemcelpro, allogeneic umbilical cord-derived CD34- cells, non-expanded,dorocubicel, Status: Opinion
11 days ago
Human medicines European public assessment report (EPAR): Zemcelpro, allogeneic umbilical cord-derived CD34-...
Human medicines European public assessment report (EPAR): Afiveg, aflibercept, Status: Opinion
11 days ago
Human medicines European public assessment report (EPAR): Afiveg, aflibercept, Status: Opinion
Human medicines European public assessment report (EPAR): Usymro, ustekinumab, Status: Opinion
11 days ago
Human medicines European public assessment report (EPAR): Usymro, ustekinumab, Status: Opinion
Human medicines European public assessment report (EPAR): Ogsiveo, nirogacestat, Status: Opinion
11 days ago
Human medicines European public assessment report (EPAR): Ogsiveo, nirogacestat, Status: Opinion